Findings

What do systematic reviews say?

4,315 questions · 23,557 findings · 2,311 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 4,183 · 17.8%GRADE not reported 3,930 · 16.7%Very low 5,371 · 22.8%Low 5,787 · 24.6%Moderate 3,320 · 14.1%High 966 · 4.1%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Antiplatelet therapy vs placebo

Stroke or transient ischaemic attack · people with cerebral small vessel disease and no dementia

1 finding from 1 review

Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without… 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 50 participants
Very low

Antiplatelet therapy vs placebo

Any adverse events (excluding major bleeding) · people with cerebral small vessel disease and no dementia

1 finding from 1 review

Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without… 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 50 participants
Very low

Antiplatelet therapy vs placebo

Withdrawal from study medication · people with cerebral small vessel disease and no dementia

1 finding from 1 review

Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without… 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 50 participants
Very low

Antiplatelet drug vs placebo

Incidence of dementia · s with mixed prevalence of antiplatelet drug use at baseline, for the prevention of cognitive decline and dementia in people with cerebral…

The review found no eligible studies for this question.

1 finding from 1 review

Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without… 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Antiplatelet drug vs placebo

Major bleeding (intracranial and extracranial) · s with mixed prevalence of antiplatelet drug use at baseline, for the prevention of cognitive decline and dementia in people with cerebral…

1 finding from 1 review

Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without… 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 280 participants
Very low

Antiplatelet drug vs placebo

Functional ability · s with mixed prevalence of antiplatelet drug use at baseline, for the prevention of cognitive decline and dementia in people with cerebral…

1 finding from 1 review

Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without… 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 280 participants
Very low

Antiplatelet drug vs placebo

Stroke or transient ischaemic attack · s with mixed prevalence of antiplatelet drug use at baseline, for the prevention of cognitive decline and dementia in people with cerebral…

1 finding from 1 review

Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without… 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 280 participants
Very low

Antiplatelet drug vs placebo

Any adverse events (excluding major bleeding) · s with mixed prevalence of antiplatelet drug use at baseline, for the prevention of cognitive decline and dementia in people with cerebral…

1 finding from 1 review

Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without… 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 280 participants
Very low

Antiplatelet drug vs placebo

Withdrawal from study medication · s with mixed prevalence of antiplatelet drug use at baseline, for the prevention of cognitive decline and dementia in people with cerebral…

1 finding from 1 review

Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without… 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 280 participants
Very low

Antiplatelet therapy vs placebo

Cognitive function · people with cerebral small vessel disease and no dementia

1 finding from 1 review

Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without… 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 50 participants
Very low

Antiplatelet therapy vs placebo

Incidence of dementia · people with cerebral small vessel disease and no dementia

The review found no eligible studies for this question.

1 finding from 1 review

Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without… 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)

Cardiovascular mortality

The review found no eligible studies for this question.

2 findings from 1 review

Non‐invasive positive pressure ventilation for central sleep apnoea in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Non‐invasive positive pressure ventilation for central sleep apnoea in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)

Serious adverse events

The review found no eligible studies for this question.

2 findings from 1 review

Non‐invasive positive pressure ventilation for central sleep apnoea in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Non‐invasive positive pressure ventilation for central sleep apnoea in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)

Quality of sleep

The review found no eligible studies for this question.

2 findings from 1 review

Non‐invasive positive pressure ventilation for central sleep apnoea in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Non‐invasive positive pressure ventilation for central sleep apnoea in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)

Quality of life

1 finding from 1 review

Non‐invasive positive pressure ventilation for central sleep apnoea in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)

AHI

2 findings from 1 review

Non‐invasive positive pressure ventilation for central sleep apnoea in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low
Non‐invasive positive pressure ventilation for central sleep apnoea in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)

All‐cause mortality

The review found no eligible studies for this question.

2 findings from 1 review

Non‐invasive positive pressure ventilation for central sleep apnoea in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Non‐invasive positive pressure ventilation for central sleep apnoea in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)

Time to life‐saving cardiovascular intervention

The review found no eligible studies for this question.

2 findings from 1 review

Non‐invasive positive pressure ventilation for central sleep apnoea in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Non‐invasive positive pressure ventilation for central sleep apnoea in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)

Central AHI

2 findings from 1 review

Non‐invasive positive pressure ventilation for central sleep apnoea in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low
Non‐invasive positive pressure ventilation for central sleep apnoea in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)

Quality of life ‐ after 3 months Number of participants: 61(1 RCT)

1 finding from 1 review

Non‐invasive positive pressure ventilation for central sleep apnoea in adults 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low